| EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | | chr9:111902874-111904791:+ | ENST00000489355.1 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluSx1,AluSp,MER5B,AluSz6,AluJb | chr9:111902874-111904791:+.alignment |
| chr9:111902874-111904791:+ | ENST00000490110.4 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluSx1,AluSp,MER5B,AluSz6,AluJb | chr9:111902874-111904791:+.alignment |
| chr9:111902874-111904791:+ | ENST00000495085.1 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluSx1,AluSp,MER5B,AluSz6,AluJb | chr9:111902874-111904791:+.alignment |
| chr9:111910836-111911821:+ | ENST00000489355.1 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluSz,AluJb,L1ME4b | chr9:111910836-111911821:+.alignment |
| chr9:111910836-111911821:+ | ENST00000490110.4 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluSz,AluJb,L1ME4b | chr9:111910836-111911821:+.alignment |
| chr9:111910836-111911821:+ | ENST00000495085.1 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluSz,AluJb,L1ME4b | chr9:111910836-111911821:+.alignment |
| chr9:111916447-111916992:+ | ENST00000490110.4 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluJb,AluJr | chr9:111916447-111916992:+.alignment |
| chr9:111916447-111916992:+ | ENST00000495085.1 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluJb,AluJr | chr9:111916447-111916992:+.alignment |
| chr9:111918056-111922090:+ | ENST00000490110.4 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluYd8,MER5A,AluY,AluSq,MamSINE1,AluJr,AluJb,AluSx,AluSz,AluSg | chr9:111918056-111922090:+.alignment |
| chr9:111918056-111922090:+ | ENST00000495085.1 | ENSG00000148154.8 | UGCG | ncRNA_intronic | AluYd8,MER5A,AluY,AluSq,MamSINE1,AluJr,AluJb,AluSx,AluSz,AluSg | chr9:111918056-111922090:+.alignment |
| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| chr9:111916447-111916992:+ | BRCA | EER | Eosinophils | 2.0633e-05 | 0.7036 |  |
| chr9:111918056-111922090:+ | BRCA | EER | Macrophages_M1 | 2.0067e-04 | 0.3636 |  |
| ENSG00000148154.8,UGCG | BRCA | EAG | Macrophages_M1 | 7.4003e-04 | 0.3213 |  |
| chr9:111916447-111916992:+ | ESCA | EER | T_cells_CD8 | 4.3599e-02 | 0.3590 |  |
| chr9:111918056-111922090:+ | ESCA | EER | Macrophages_M1 | 1.9624e-02 | 0.2726 |  |
| ENSG00000148154.8,UGCG | ESCA | EAG | Macrophages_M1 | 2.1017e-02 | 0.2610 |  |
| ENSG00000148154.8,UGCG | KIRC | EAG | T_cells_CD4_memory_activated | 1.6011e-03 | 0.5595 |  |
| ENSG00000148154.8,UGCG | LUAD | EAG | Eosinophils | 4.0387e-02 | -0.4506 |  |
| chr9:111918056-111922090:+ | OV | EER | T_cells_CD8 | 5.0365e-05 | 0.7089 |  |
| ENSG00000148154.8,UGCG | OV | EAG | Macrophages_M0 | 4.0080e-02 | -0.3769 |  |
| chr9:111910836-111911821:+ | STAD | EER | Macrophages_M2 | 3.1052e-02 | 0.3256 |  |
| chr9:111916447-111916992:+ | STAD | EER | T_cells_CD4_memory_activated | 4.8080e-03 | 0.3964 |  |
| chr9:111918056-111922090:+ | STAD | EER | T_cells_CD4_memory_activated | 2.5702e-02 | 0.1987 |  |
| ENSG00000148154.8,UGCG | STAD | EAG | Macrophages_M2 | 4.3461e-02 | 0.1679 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| chr9:111916447-111916992:+ | BRCA | GSVA_HALLMARK_P53_PATHWAY | EER | 2.6993e-03 | 0.5365 |  |
| ENSG00000148154.8,UGCG | BRCA | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 1.6255e-11 | 0.5934 |  |
| chr9:111918056-111922090:+ | BRCA | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 1.7614e-11 | 0.6091 |  |
| chr9:111918056-111922090:+ | ESCA | GSVA_HALLMARK_HYPOXIA | EER | 9.6027e-03 | 0.3012 |  |
| chr9:111916447-111916992:+ | ESCA | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EER | 6.3826e-04 | 0.5712 |  |
| ENSG00000148154.8,UGCG | ESCA | GSVA_HALLMARK_HYPOXIA | EAG | 8.1778e-03 | 0.2974 |  |
| ENSG00000148154.8,UGCG | KIRC | GSVA_HALLMARK_G2M_CHECKPOINT | EAG | 4.5254e-03 | 0.5120 |  |
| ENSG00000148154.8,UGCG | KIRP | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 2.8897e-02 | 0.3991 |  |
| chr9:111918056-111922090:+ | KIRP | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 3.0064e-02 | 0.3965 |  |
| ENSG00000148154.8,UGCG | LUAD | GSVA_HALLMARK_APICAL_JUNCTION | EAG | 7.1817e-05 | 0.7567 |  |
| ENSG00000148154.8,UGCG | STAD | GSVA_HALLMARK_SPERMATOGENESIS | EAG | 8.5694e-04 | 0.2739 |  |
| chr9:111918056-111922090:+ | STAD | GSVA_HALLMARK_ANDROGEN_RESPONSE | EER | 1.1387e-04 | 0.3370 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| chr9:111916447-111916992:+ | BRCA | JNK.Inhibitor.VIII | EER | 8.9350e-03 | 0.4767 |  |
| ENSG00000148154.8,UGCG | BRCA | Methotrexate | EAG | 8.9337e-08 | 0.4892 |  |
| chr9:111918056-111922090:+ | BRCA | MG.132 | EER | 4.5425e-07 | -0.4793 |  |
| chr9:111918056-111922090:+ | ESCA | CMK | EER | 1.1731e-02 | -0.2935 |  |
| chr9:111916447-111916992:+ | ESCA | ABT.888 | EER | 2.7583e-03 | -0.5117 |  |
| ENSG00000148154.8,UGCG | ESCA | CMK | EAG | 4.6362e-03 | -0.3174 |  |
| chr9:111918056-111922090:+ | KIRC | LFM.A13 | EER | 4.0626e-02 | -0.4207 |  |
| ENSG00000148154.8,UGCG | KIRC | FTI.277 | EAG | 1.9575e-04 | -0.6381 |  |
| ENSG00000148154.8,UGCG | KIRP | AG.014699 | EAG | 4.2494e-03 | 0.5070 |  |
| chr9:111918056-111922090:+ | KIRP | AG.014699 | EER | 4.1967e-03 | 0.5075 |  |
| ENSG00000148154.8,UGCG | LUAD | Bexarotene | EAG | 7.9049e-04 | -0.6749 |  |
| chr9:111918056-111922090:+ | OV | A.770041 | EER | 4.9964e-03 | -0.5336 |  |
| ENSG00000148154.8,UGCG | SKCM | Erlotinib | EAG | 7.5464e-03 | -0.5784 |  |
| chr9:111910836-111911821:+ | STAD | AZD.2281 | EER | 3.8865e-03 | -0.4265 |  |
| ENSG00000148154.8,UGCG | STAD | GW.441756 | EAG | 4.3458e-02 | -0.1680 |  |
| chr9:111916447-111916992:+ | STAD | Cisplatin | EER | 2.1597e-02 | -0.3275 |  |
| chr9:111918056-111922090:+ | STAD | Erlotinib | EER | 1.0891e-02 | -0.2270 |  |